CClinicalTrials.gg
TerminatedNCT00629850Updated May 8, 2019Results posted

Respiratory Resistance Training on Sleep Quality in Persons With Spinal Cord Injury

An interventional study of Powerlung Performer in Spinal Cord Injury, sponsored by Texas State University, San Marcos. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-05-08.

Sponsored by Texas State University, San Marcos · Not applicable, Interventional, and Treatment

Why this study was terminated
unable to recruit participants.
Phase
Not applicable
Study type
Interventional
Enrollment
1
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine if the use of a respiratory resistance trainer will increase respiratory muscle strength, improve sleep quality and improve quality of life in individuals with spinal cord injury.

Hypothesis: Use of the respiratory resistance trainer will improve respiratory muscle strength, improve sleep quality, and improve quality of life among individuals with spinal cord injury.

Read the detailed description

Individuals with spinal cord injury experience varying degrees of reduced muscle function. Those individuals with high level spinal cord injury, cervical region, may experience reduced diaphragm function. This reduction in function may affect daytime activities as well as sleep quality. Sleep quality in people with spinal cord injury is considered to be worse than sleep quality in the general population. The use of respiratory resistance training devices has been shown to increase muscle strength in people with spinal cord injury. There have been not studies to document potential improvements in sleep quality among individuals with spinal cord injury following respiratory resistance training.

02

Conditions studied

  • Spinal Cord Injury

Keywords

  • spinal cord injury
  • respiratory muscle training
  • sleep quality
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 1 is below the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Texas State University, San Marcos is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • tetraplegia
  • quadriplegia

Exclusion criteria

Exclusion Criteria:

  • NA
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
1 participant (actual)

Study arms

  • Experimental
    Powerlung Performer

    The arm will receive the lung trainer device to use for 10 weeks

    Device: Powerlung Performer

  • No intervention
    Control

    Control. This arm will not receive any device

Interventions

  • DevicePowerlung Performer

    Inspiratory/Expiratory muscle trainer

    Also known as: Respiratory resistance trainer

06

What researchers measure

Primary outcomes

  1. Number of Participants With Improvement in Sleep Quality.

    Improvement in sleep quality as defined by: less fragmented sleep, lower apnea hypopnea index (AHI), respiratory disturbance index (RDI) after device use.

    Time frame: 10 weeks

  2. Change in Maximum Voluntary Ventilation Using Pulmonary Function Device

    Pulmonary function device measures flow rate in liters per minute over a period of at least 12 seconds.

    Time frame: 10 weeks

  3. Change in Negative Inspiratory Force Using a Pressure Manometer

    Time frame: 10 weeks

07

Results

Posted Aug 18, 2011
Limitations and caveats
Unable to recruit subjects for the study

Participant flow

Participant flow — Overall Study
MilestonePowerlung Trainer DeviceControl
Started10
Completed10
Not completed00

Outcome measures

PrimaryNumber of Participants With Improvement in Sleep Quality.

Improvement in sleep quality as defined by: less fragmented sleep, lower apnea hypopnea index (AHI), respiratory disturbance index (RDI) after device use.

Time frame:
10 weeks

No measurements were reported for this outcome.

PrimaryChange in Maximum Voluntary Ventilation Using Pulmonary Function Device

Pulmonary function device measures flow rate in liters per minute over a period of at least 12 seconds.

Time frame:
10 weeks

No measurements were reported for this outcome.

PrimaryChange in Negative Inspiratory Force Using a Pressure Manometer
Time frame:
10 weeks

No measurements were reported for this outcome.

Adverse events

Collected over 8 weeks of data collection. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Powerlung Trainer Device—0/1 (0%)0/1 (0%)
Control———

Baseline characteristics

This was a single subject case study. No control subjects.

Age, Categorical
Age, Categorical(Participants)Powerlung Trainer DeviceControlTotal
<=18 years000
Between 18 and 65 years101
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Powerlung Trainer DeviceControlTotal
Female000
Male101
Region of Enrollment
Region of Enrollment(participants)Powerlung Trainer DeviceControlTotal
United States1—1
08

Study locations

1 site
  • Texas State University-San Marcos
    San Marcos, Texas 78666, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00629850
Lead sponsor
Texas State University, San Marcos
Responsible party
Chris Russian (Principal Investigator, Texas State University, San Marcos) — Principal investigator
First posted
Mar 6, 2008
Start date
Feb 2008
Primary completion
Sep 2009
Completion
Sep 2009
Results posted
Aug 18, 2011
Last update
May 8, 2019

Study contacts

Lisa Lloyd, Ph.D.
study chair · Texas State University, San Marcos

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion